ResMed Inc. (RMD) Dividend History

ResMed Inc. is a healthcare company that specializes in developing, manufacturing, and marketing medical equipment primarily for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Founded in 1989, the company is known for its innovative sleep and respiratory care solutions, including devices such as CPAP machines, ventilators, and related accessories. ResMed operates globally, serving both individual patients and healthcare providers.

9001 Spectrum Center Blvd., San Diego, CA, 92123
Phone: (858) 746-2400
Website: https://www.resmed.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
June 12, 2025	$0.53	05/08/2025	05/08/2025
March 20, 2025	$0.53	02/13/2025	02/13/2025
December 12, 2024	$0.53	11/07/2024	11/07/2024
September 19, 2024	$0.53	08/15/2024	08/15/2024
June 13, 2024	$0.48	05/08/2024	05/09/2024
March 14, 2024	$0.48	02/07/2024	02/08/2024
December 14, 2023	$0.48	11/08/2023	11/09/2023
September 21, 2023	$0.48	08/16/2023	08/17/2023
June 15, 2023	$0.44	05/10/2023	05/11/2023
March 16, 2023	$0.44	02/08/2023	02/09/2023
December 15, 2022	$0.44	11/09/2022	11/10/2022
September 22, 2022	$0.44	08/17/2022	08/18/2022
June 16, 2022	$0.42	05/11/2022	05/12/2022
March 17, 2022	$0.42	02/09/2022	02/10/2022
December 16, 2021	$0.42	11/09/2021	11/11/2021
September 23, 2021	$0.42	08/18/2021	08/19/2021
June 17, 2021	$0.39	05/12/2021	05/13/2021
March 18, 2021	$0.39	02/10/2021	02/11/2021
December 17, 2020	$0.39	11/10/2020	11/12/2020
September 24, 2020	$0.39	08/19/2020	08/20/2020
June 18, 2020	$0.39	05/13/2020	05/14/2020
March 19, 2020	$0.39	02/12/2020	02/13/2020
December 12, 2019	$0.39	11/06/2019	11/07/2019
September 19, 2019	$0.39	08/14/2019	08/15/2019
June 13, 2019	$0.37	05/08/2019	05/09/2019
March 14, 2019	$0.37	02/06/2019	02/07/2019
December 13, 2018	$0.37	11/07/2018	11/08/2018
September 20, 2018	$0.37	08/15/2018	08/16/2018
June 14, 2018	$0.35	05/09/2018	05/10/2018
March 15, 2018	$0.35	02/07/2018	02/08/2018
December 14, 2017	$0.35	11/08/2017	11/09/2017
September 21, 2017	$0.35	08/15/2017	08/17/2017
June 15, 2017	$0.33	05/09/2017	05/11/2017
March 16, 2017	$0.33	02/07/2017	02/09/2017
December 15, 2016	$0.33	11/08/2016	11/10/2016
September 22, 2016	$0.33	08/16/2016	08/18/2016
June 16, 2016	$0.30	05/17/2016	05/19/2016
March 17, 2016	$0.30	02/09/2016	02/11/2016
December 17, 2015	$0.30	11/17/2015	11/19/2015
September 17, 2015	$0.30	08/18/2015	08/20/2015
June 18, 2015	$0.28	05/19/2015	05/21/2015
March 19, 2015	$0.28	02/10/2015	02/12/2015
December 18, 2014	$0.28	11/18/2014	11/20/2014
September 18, 2014	$0.28	08/19/2014	08/21/2014
June 17, 2014	$0.25	05/16/2014	05/20/2014
March 19, 2014	$0.25	02/14/2014	02/19/2014
December 18, 2013	$0.25	11/15/2013	11/19/2013
September 17, 2013	$0.25	08/16/2013	08/20/2013
June 18, 2013	$0.17	05/17/2013	05/21/2013
March 19, 2013	$0.17	02/14/2013	02/19/2013
December 18, 2012	$0.17	11/16/2012	11/20/2012
September 28, 2012	$0.17	09/05/2012	09/07/2012

Dividends Summary

ResMed Inc. has issued 52 dividend payments over the past 13 years
The most recent dividend was paid 79 days ago, on March 20, 2025
The first recorded dividend was paid on September 28, 2012
The highest dividend payout was $0.53 per share
The average dividend over this 13 year span is $0.36 per share
ResMed Inc. has increased its dividend payments by 211.76% since 2012

Company News

Actigraphy Devices Market Report 2025-2034 | Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape

The global actigraphy devices market is expected to grow at a CAGR of 6.4% from 2025 to 2034, driven by the rising prevalence of sleep disorders, advancements in wearable technology, and increased awareness of sleep health.

GlobeNewswire Inc.

Featured Companies: AAPL GRMN PHG
ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

ResMed reported strong Q3 results with double-digit EPS growth and a tariff exemption, leading analysts to boost their price forecasts for the company.

Benzinga
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Resmed Inc. reported strong financial results for the third quarter of fiscal year 2025, with 9% constant currency revenue growth, 140 basis points improvement in non-GAAP gross margin, and double-digit EPS growth. The company's sleep and breathing health products and software solutions continue to see solid customer demand.

Benzinga
Resmed Names Salli Schwartz as Chief Investor Relations Officer

Resmed, a global leader in health technology, has appointed Salli Schwartz as its new Chief Investor Relations Officer. Schwartz brings extensive experience from her previous roles at Illumina, MSCI, and Moody's, and will lead Resmed's global investor relations function.

GlobeNewswire Inc.

Featured Companies: ILMN MCO MSCI
$5.37 Bn Ventilator Market Forecasts 2025-2030: Emergence of More Patient-friendly, Cost-effective, and Portable Devices Fueling Expansion

The global ventilator market is projected to grow at a CAGR of 6.65% to reach $7.416 billion by 2030, driven by the rise in respiratory emergencies, COPD, and technological innovations in respiratory care devices. Manufacturers are focusing on creating cost-efficient, non-invasive ventilation solutions to cater to local needs.

GlobeNewswire Inc.

Featured Companies: MDT PHG

Dividend data last updated 06/07/2025 02:44:02 UTC

ResMed Inc. (RMD) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies